Prostate cancer remains one of the most common malignancies in men worldwide, ranking as the second most prevalent cancer and ...

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone therapy to radiation after surgery - the ...

A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of androgen deprivation therapy (ADT) for prostate cancer occur within the first ...

Newswise — Research team led by UH Seidman Cancer Center and UCLA published results in The Lancet; Presented at the American Society of Clinical Oncology Genitourinary Symposium Study shows adding ...

The trial added 177Lu-PNT2002 to stereotactic body radiation therapy (SBRT) and found that median progression-free survival ...

A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of androgen deprivation therapy (ADT) for prostate cancer occur within the first ...

Hormone Therapy Might Be Unnecessary For Some Prostate Cancer Patients By Dennis Thompson HealthDay ReporterMONDAY, March 2, 2026 (HealthDay News) — Some men who’ve had surgery for prostate cancer can ...

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that while traditional pathological features used to classify aggressive prostate cancer—such as ...

SAN FRANCISCO -- Adding hormone therapy to postoperative radiotherapy did not improve overall survival (OS) for most men with prostate cancer, according to a meta-analysis of individual patient data.

Please provide your email address to receive an email when new articles are posted on . A genetic test that identifies the PAM50 biomarker predicted which patients with recurrent prostate cancer would ...

Salvage radiation after surgery: If PSA rises after surgery, radiation to the area where the prostate was can still be ...